These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8602107
1. Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat. Kashihara K, Akiyama K, Ishihara T, Shiro Y, Shohmori T. Life Sci; 1996; 58(10):PL 159-70. PubMed ID: 8602107 [Abstract] [Full Text] [Related]
2. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. Andersson M, Konradi C, Cenci MA. J Neurosci; 2001 Dec 15; 21(24):9930-43. PubMed ID: 11739600 [Abstract] [Full Text] [Related]
3. Synergistic effect of D1 and D2 dopamine receptors on AP-1 DNA-binding activity in the striatum and globus pallidus of the rat with a unilateral 6-OHDA lesion of the medical forebrain bundle. Kashihara K, Akiyama K, Ishihara T, Shiro Y, Shohmori T. Life Sci; 1996 Dec 15; 59(20):1683-93. PubMed ID: 8890942 [Abstract] [Full Text] [Related]
4. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Oh JD, Vaughan CL, Chase TN. Brain Res; 1999 Mar 13; 821(2):433-42. PubMed ID: 10064831 [Abstract] [Full Text] [Related]
5. D1/D2 receptor synergism on CREB DNA-binding activities in the caudate-putamen of rat. Kashihara K, Ishihara T, Akiyama K, Abe K. Neurol Res; 1999 Dec 13; 21(8):781-4. PubMed ID: 10596389 [Abstract] [Full Text] [Related]
6. Levodopa induces AP-1 and CREB DNA-binding activities in the rat striatum. Kashihara K, Ishihara T, Akiyama K, Kuroda S, Morimasa T, Shomori T. Psychiatry Clin Neurosci; 1995 Dec 13; 49(5-6):291-4. PubMed ID: 8726116 [Abstract] [Full Text] [Related]
7. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. Pollack AE, Fink JS. Brain Res; 1996 Dec 16; 743(1-2):124-30. PubMed ID: 9017239 [Abstract] [Full Text] [Related]
8. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B, Crossman AR, Brotchie JM. Exp Neurol; 1999 Feb 16; 155(2):204-20. PubMed ID: 10072296 [Abstract] [Full Text] [Related]
9. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Pollack AE, Thomas LI. Pharmacol Biochem Behav; 2010 Jan 16; 94(3):346-51. PubMed ID: 19800912 [Abstract] [Full Text] [Related]
10. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease. Lindgren HS, Ohlin KE, Cenci MA. Neuropsychopharmacology; 2009 Nov 16; 34(12):2477-88. PubMed ID: 19606087 [Abstract] [Full Text] [Related]
11. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat. Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M. Synapse; 2008 Jul 16; 62(7):524-33. PubMed ID: 18435422 [Abstract] [Full Text] [Related]
12. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Cole DG, Kobierski LA, Konradi C, Hyman SE. Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9631-5. PubMed ID: 7937819 [Abstract] [Full Text] [Related]
13. Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum. Huang KX, Walters JR. Neuroscience; 1996 Dec 27; 75(3):757-75. PubMed ID: 8951871 [Abstract] [Full Text] [Related]
15. Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats. Ueda H, Sato K, Okumura F, Inoue A, Nakata Y, Ozaki N, Yue JL, Misu Y. Biomed Pharmacother; 1995 Dec 28; 49(4):169-77. PubMed ID: 7669936 [Abstract] [Full Text] [Related]
16. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. Ballion B, Frenois F, Zold CL, Chetrit J, Murer MG, Gonon F. Neurobiol Dis; 2009 Sep 28; 35(3):376-84. PubMed ID: 19501163 [Abstract] [Full Text] [Related]
17. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat. Nash JE, Brotchie JM. Mov Disord; 2002 May 28; 17(3):455-66. PubMed ID: 12112191 [Abstract] [Full Text] [Related]
18. Effects of bromocriptine on dopamine turnover with or without levodopa. Ogawa N, Asanuma M, Tanaka K, Matsuura K, Iida K, Yamamoto M. J Int Med Res; 1996 May 28; 24(3):271-7. PubMed ID: 8725988 [Abstract] [Full Text] [Related]
19. ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. Shiosaki K, Jenner P, Asin KE, Britton DR, Lin CW, Michaelides M, Smith L, Bianchi B, Didomenico S, Hodges L, Hong Y, Mahan L, Mikusa J, Miller T, Nikkel A, Stashko M, Witte D, Williams M. J Pharmacol Exp Ther; 1996 Jan 28; 276(1):150-60. PubMed ID: 8558425 [Abstract] [Full Text] [Related]
20. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens. Yamada H, Kuroki T, Nakahara T, Hashimoto K, Tsutsumi T, Hirano M, Maeda H. Brain Res; 2007 Feb 02; 1131(1):88-96. PubMed ID: 17169339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]